Comparison of three doses of amikacin on alternate days with a daily dose of meropenem during the same period for the treatment of urinary tract infection with E. coli: a double-blind clinical trial

Table 5 Frequency distribution of the measured variables following one week of treatment

Variable	Groups	Value	P-value
Fever	Amikacin	0	-
Fever	Meropenem	0	-
Dysuria	Amikacin	2 (7.1%)	0.58 *
Dysuria	Meropenem	1 (3%)	0.58 *
Frequent urination	Amikacin	2 (7.1%)	0.2 *
Frequent urination	Meropenem	0	0.2 *
Abdominal pain	Amikacin	1 (3.6%)	1 *
Abdominal pain	Meropenem	1 (3%)	1 *
Flank pain	Amikacin	2 (7.1%)	0.58 *
Flank pain	Meropenem	1 (3%)	0.58 *
Suprapubic pain	Amikacin	2 (7.1%)	0.58 *
Suprapubic pain	Meropenem	1 (3%)	0.58 *
Costovertebral angle tenderness (CVAT)	Amikacin	0	-
Costovertebral angle tenderness (CVAT)	Meropenem	0	-

ISSN: 1756-0500